According to reports, the passage of two bills within Michigan’s legislature – which will allow Blue Cross and Blue Shield of Michigan to convert itself into a nonprofit health insurer – could potentially negate some allegations currently standing against BCBS brought by the Department of Justice and Aetna Inc. claiming that the insurance company abused its dominance. Senate Bills 1293 and 1294 include a provision that would require BCBS of Michigan to stop enforcing “most favored nation” clauses in hospital contracts; In 2010 the DOJ brought charges against the health insurer claiming it forced 22 Michigan hospitals into “most favored nation-plus” contracts, which force the hospitals to charge higher prices to competing health insurers. The new legislation would also require Blue Cross to contribute a “fair share” of reimbursement to hospitals “to account for underfunded government programs and uncompensated care.” The new legislation could potentially mean some legal leniency in the insurer’s current antitrust cases with the DOJ and Aetna Inc., as the DOJ is only asking that Blue Cross stop using most-favored-nation clauses in contracts, a request that would be taken care of by new law.
Featured News
House Votes to Pass CLARITY Act After Drama Threatened to Derail Crypto Market Structure Bill
Jul 17, 2025 by
CPI
Zillow Rejects Compass’s Antitrust Claims Amid Listing Policy Dispute
Jul 17, 2025 by
CPI
DOJ Probes ServiceNow’s $2.85B AI Merger with Moveworks
Jul 17, 2025 by
CPI
Authors Can Sue Anthropic Over Alleged AI Book Piracy, Judge Rules
Jul 17, 2025 by
CPI
Charter, Cox Request FCC Green Light for $34.5B Merger
Jul 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Surveillance Pricing
Jul 14, 2025 by
CPI
Should We Fear Personalized Pricing?
Jul 14, 2025 by
John Yun
Data and Price Competition: The Special Role of Information About Rivals’ Prices
Jul 14, 2025 by
Zach Y. Brown & Alexander MacKay
Surveillance Pricing: A Cautionary Summary of Potential Harms and Solutions
Jul 14, 2025 by
Ginger Zhe Jin, Liad Wagman & Mengyi Zhong
The Rise of Surveillance Pricing
Jul 14, 2025 by
Rebecca Kirk Fair, Alvaro Ziadi & Juan Carvajal